These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8987073)

  • 1. Guidance in the setting of drug particle size specifications to minimize variability in absorption.
    Johnson KC; Swindell AC
    Pharm Res; 1996 Dec; 13(12):1795-8. PubMed ID: 8987073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fraction of a dose absorbed estimation for structurally diverse low solubility compounds.
    Sugano K
    Int J Pharm; 2011 Feb; 405(1-2):79-89. PubMed ID: 21134428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixing-tank model for predicting dissolution rate control or oral absorption.
    Dressman JB; Fleisher D
    J Pharm Sci; 1986 Feb; 75(2):109-16. PubMed ID: 3958917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
    Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect.
    Sugano K
    Int J Pharm; 2010 Mar; 387(1-2):103-9. PubMed ID: 20006692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs.
    Macheras P; Iliadis A; Melagraki G
    Eur J Pharm Sci; 2018 May; 117():98-106. PubMed ID: 29425862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational oral absorption simulation of free base drugs.
    Sugano K
    Int J Pharm; 2010 Oct; 398(1-2):73-82. PubMed ID: 20655999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The composite solubility versus pH profile and its role in intestinal absorption prediction.
    Hendriksen BA; Felix MV; Bolger MB
    AAPS PharmSci; 2003; 5(1):E4. PubMed ID: 12713276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution of slightly soluble drugs. V. Effect of particle size on gastrointestinal drug absorption and its relation to solubility.
    Kaneniwa N; Watari N; Iijima H
    Chem Pharm Bull (Tokyo); 1978 Sep; 26(9):2603-14. PubMed ID: 699204
    [No Abstract]   [Full Text] [Related]  

  • 11. A computational model for particle size influence on drug absorption during controlled-release colonic delivery.
    Waterman KC; Sutton SC
    J Control Release; 2003 Jan; 86(2-3):293-304. PubMed ID: 12526825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical model for dose-dependent drug absorption.
    Dressman JB; Fleisher D; Amidon GL
    J Pharm Sci; 1984 Sep; 73(9):1274-9. PubMed ID: 6548523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction Characteristics of Oral Absorption Simulation Software Evaluated Using Structurally Diverse Low-Solubility Drugs.
    Matsumura N; Hayashi S; Akiyama Y; Ono A; Funaki S; Tamura N; Kimoto T; Jiko M; Haruna Y; Sarashina A; Ishida M; Nishiyama K; Fushimi M; Kojima Y; Yoneda K; Nakanishi M; Kim S; Fujita T; Sugano K
    J Pharm Sci; 2020 Mar; 109(3):1403-1416. PubMed ID: 31863733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating drug solubility in the gastrointestinal tract.
    Dressman JB; Vertzoni M; Goumas K; Reppas C
    Adv Drug Deliv Rev; 2007 Jul; 59(7):591-602. PubMed ID: 17599644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of biowaivers among Class II drugs: theoretical justification and practical examples.
    Rinaki E; Dokoumetzidis A; Valsami G; Macheras P
    Pharm Res; 2004 Sep; 21(9):1567-72. PubMed ID: 15497681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of biorelevant simulated media mimicking the intestinal environment to assess the solubility profiles of poorly soluble drugs.
    Prasad D; Gu CH; Kuldipkumar A
    Pharm Dev Technol; 2016; 21(4):511-7. PubMed ID: 25703029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polar molecular surface properties predict the intestinal absorption of drugs in humans.
    Palm K; Stenberg P; Luthman K; Artursson P
    Pharm Res; 1997 May; 14(5):568-71. PubMed ID: 9165525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rule of unity for human intestinal absorption 3: Application to pharmaceuticals.
    Patel RB; Yalkowsky SH
    Biopharm Drug Dispos; 2018 Feb; 39(2):67-74. PubMed ID: 29127714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models.
    Sjögren E; Thörn H; Tannergren C
    Mol Pharm; 2016 Jun; 13(6):1763-78. PubMed ID: 26926043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.